Skip to main content
. 2012 Oct 31;7(10):e47459. doi: 10.1371/journal.pone.0047459

Table 3. Score, rank and inter-class correlation of point-of-care technologies assessed with the scorecard.

Analyzer Category Product Average Score (Range) Mean Rank p-value Percent of Top Score in Category Intra-class correlation*
CD4 T+ cell count 1 4.00 (3.83–4.08) 1 p = 0.125 100.0% 0.862 (0.777–0.924)
2 3.06 (2.82–3.16) 2 76.4% 0.845 (0.755–0.916)
Multiple-parameter clinical chemistry 1 3.89 (3.79–4.04) 1 p = 0.01 100.0% 0.865 (0.782–0.926)
2 3.56 (3.46–3.66) 2 91.4% 0.927 (0.879–0.961)
3 3.33 (3.29–3.43) 3.25 85.7% 0.852 (0.762–0.918)
4 3.26 (3.14–3.44) 3.75 83.8% 0.873 (0.794–0.931)
5 3.07 (2.99–3.23) 5 78.8% 0.921 (0.868–0.958)
6 2.78 (2.65–2.88) 6 71.4% 0.959 (0.931–0.978)
Limited-parameter clinical chemistry 1 4.15 (3.98–4.40) 1 p = 0.001 100.0% 0.864 (0.776–0.926)
2 4.10 (3.96–4.30) 2 98.8% 0.881 (0.805–0.935)
3 3.89 (3.76–3.96) 3.25 93.7% 0.955 (0.924–0.976)
4 3.39 (3.18–3.76) 3.75 81.8% 0.834 (0.735–0.908)
Multiple-parameter hematology 1 3.75 (3.56–3.94) 1 p = 0.069 100.0% 0.855 (0.767–0.920)
2 3.73 (3.58–3.84) 2.5 99.5% 0.979 (0.683–0.886)
3 2.96 (2.66–3.12) 2.5 79.1% 0.837 (0.738–0.909)
Limited-parameter hematology 1 4.17 (4.01–4.40) 1 p = 0.001 100.0% 0.974 (0.955–0.986)
2 3.75 (3.61–3.88) 2 90.0% 0.905 (0.844–0.949)
3 3.62 (3.55–3.70) 1.25 86.8% 0.972 (0.952–0.985)
4 3.57 (3.46–3.64) 1.75 85.6% 0.802 (0.688–0.888)
*

all p-values<0.0001.